Synta to Participate in Upcoming Investor Conferences
Get Alerts SNTA Hot Sheet
Join SI Premium – FREE
- Presenting at JMP Securities Life Sciences Conference 2015 -
- Participating in 2nd Annual ROTH Healthcare Corporate Access Day -
LEXINGTON, Mass.--(BUSINESS WIRE)-- Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will present at the JMP Securities Life Sciences Conference 2015 on Tuesday, June 23rd at 12:30 p.m. (ET) in New York.
A live audio webcast and replay of the presentation will be available on the "Investors" section of the Company's website, www.syntapharma.com.
Synta will also be participating in the 2nd Annual ROTH Healthcare Corporate Access Day on Wednesday, June 24th in London. There is no formal presentation during the conference, however, management will be available for one-on-one meetings.
About Synta Pharmaceuticals
Synta Pharmaceuticals Corp. is an innovative, agile biopharmaceutical company focused on research, development and commercialization of novel oncology medicines that have the potential to change the lives of cancer patients. Synta’s lead oncology drug candidate, ganetespib, a novel heat shock protein 90 (Hsp90) inhibitor, is currently being evaluated in several clinical trials including the pivotal GALAXY-2 Phase 3 trial in non-small cell lung cancer. Building on its extensive expertise in the science of Hsp90, Synta also has a novel proprietary Hsp90 inhibitor Drug Conjugate (HDC) small molecule drug development program. IND enabling studies have commenced for the first clinical candidate from the HDC program, STA-12-8666, and preclinical evaluation of additional HDC candidates is ongoing. For more information, please visit www.syntapharma.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150616006648/en/
Investors:
Synta Pharmaceuticals Corp.
Daniel Cole,
781-541-7250
[email protected]
or
Argot
Partners
Andrea Rabney, 212-600-1494
[email protected]
or
Media:
Argot
Partners
Eliza Schleifstein, 917-763-8106
[email protected]
Source: Synta Pharmaceuticals Corp.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Monster Energy Team Riders Claim Medals in Key Events on Day 1 of X Games Chiba 2026
- "BLEACH Mirrors High" Begins Closed Beta Test Applications, Unveils New Trailer and New Soul Reapers at Anime Expo 2026
- How to Spot a Meme Coin Before It Runs: The 2026 Signals and Bullski’s Priority List
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share